Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Nutex Health Inc. (NUTX) had Revenue of $267.80M for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$267.80M
Net Income	$55.44M
Cost of Goods Sold	$112.92M
Gross Profit	$154.88M
Operating Expenses	$137.44M
Operating Income	$130.37M
Non-Operating Income/Expense	$-6.43M
Pre-Tax Income	$123.94M
Normalized Pre-Tax Income	$123.94M
Income after Taxes	$96.80M
Income from Continuous Operations	$96.80M
Consolidated Net Income/Loss	$96.80M
Normalized Income after Taxes	$96.80M
EBIT	$130.37M
EBITDA	$135.37M
Weighted-Average Shares Outstanding (Basic)	6.70M
Weighted-Average Shares Outstanding (Diluted)	7.18M
Earnings per Share (EPS) (Basic)	$8.27
Earnings per Share (EPS) (Diluted)	$7.76
Balance Sheet Financials
Current Assets	$592.65M
Property, Plant, and Equipment	$82.82M
Long-Term Assets	$371.87M
Total Assets	$964.52M
Current Liabilities	$185.46M
Long-Term Debt	$295.65M
Long-Term Liabilities	$341.03M
Total Liabilities	$526.49M
Common Equity	$438.03M
Tangible Shareholders Equity	$402.56M
Shareholders Equity	$438.03M
Common Shares Outstanding	6.91M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$177.74M
Cash Flow from Investing Activities	$-0.17M
Cash Flow from Financial Activities	$-52.16M
Beginning Cash	$40.64M
End Cash	$166.05M
Increase/Decrease in Cash	$125.41M
Stock-Based Compensation	$119.61M
Common Stock Dividends Paid	$-42.17M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.20
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.40
Debt to Equity Ratio	0.74
Gross Margin	57.83%
Operating Margin	48.68%
EBIT Margin	48.68%
EBITDA Margin	--
Pre-Tax Profit Margin	46.28%
Profit Margin	20.70%
Free Cash Flow	$176.62M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.28
Inventory Turnover	35.76
Receiveable Turnover	0.66
Days Sales in Receivables	136.73
Return on Equity	22.10%
Return on Tangible Equity	24.05%
Return on Assets	10.04%
Return on Investments	13.19%
Book Value Per Share	$63.44
Free Cash Flow per Share	$24.61
Operating Cash Flow per Share	$24.76

Data from Zacks Investment Research, Inc.